GHK-Cu copper peptide: chemistry, research and UK status

Research-use notice: this article is for legitimate laboratory and educational research only. It does not provide guidance for human use, administration, dosing or treatment.

GHK-Cu is the copper(II) complex of GHK (glycyl-histidyl-lysine), a three-amino-acid peptide that Loren Pickart first isolated from human plasma in 1973. It is what most people mean by “copper peptide”, it appears on cosmetic labels as copper tripeptide-1, and its blue colour comes from the bound copper. Its research record is mainly cell culture, rat wound models and gene-expression analyses. It is not a licensed medicine in the UK, and none of that work shows an effect in people.

What is GHK-Cu?

GHK is a tripeptide: glycine, histidine and lysine, joined in that order. GHK-Cu is the same peptide with a copper(II) ion bound to it. The names are often used interchangeably, but GHK on its own is a white peptide powder, while GHK-Cu is a metal complex with its own colour, chemistry and testing requirements.

Pickart isolated the tripeptide in 1973 from the albumin fraction of human plasma. In 1980 he and colleagues reported in Nature that it readily forms complexes with copper(II) and increased copper uptake into cultured liver-cancer (hepatoma) cells. A 2018 review by Pickart and Margolina notes that most authors attribute GHK’s effects in experimental systems to its ability to bind copper(II).

“Copper peptide” is an informal term for any peptide that carries copper. In skin care it almost always means GHK-Cu, listed in a 2020 Frontiers in Chemistry review under its ingredient name, copper tripeptide-1.

How does GHK bind copper?

A 2020 study in the International Journal of Molecular Sciences describes GHK holding copper(II) through three nitrogen atoms: the free amine at the glycine end, the backbone nitrogen between glycine and histidine, and a nitrogen in histidine’s imidazole ring. A 2021 study in Inorganic Chemistry reports the same three binding sites. That leaves a fourth position on the copper open, where another small molecule can attach.

The binding is very tight: the 2020 authors report a conditional dissociation constant of 0.24 picomolar at pH 7.4. Pickart and Margolina describe GHK as able to take copper(II) from its transport site on albumin, the main plasma protein. The 2020 study also found that GHK, copper and cis-urocanic acid, a molecule found in skin, can form a mixed (ternary) complex, and proposed that such forms may exist in the body. That is solution chemistry, not a measurement in living tissue.

A solution is not always a single species. The same study identified several copper forms, including one with two GHK molecules per copper ion, and found that excess GHK shifted the absorption maximum by 27 nm. So the peptide-to-copper ratio, the pH and any unbound copper are part of the material’s identity.

Why is GHK-Cu blue?

Because of the copper. The 2021 Inorganic Chemistry study reports a visible absorption band for the copper–GHK complex at 606 nm, in the orange part of the spectrum. A substance that absorbs orange light looks blue, so GHK-Cu powder and its solutions are blue, while GHK without copper is white.

The colour shows that copper is present. It does not show how much of that copper is bound to GHK, how much peptide is in the vial or how pure it is. Simple copper salts are blue too, so colour alone cannot tell a well-made batch from a poor one.

What does the research on GHK-Cu cover?

The research falls into a few distinct lines, almost all laboratory or animal work. None is a clinical trial of research-grade GHK-Cu.

Fibroblast and collagen studies

In 1988 Maquart and colleagues, Pickart among them, reported in FEBS Letters that GHK-Cu increased collagen synthesis by human fibroblasts grown from skin samples, and that the change did not depend on a change in cell number. Much of the later skin research builds on fibroblast work of this kind.

Rat wound models

A 1993 study in the Journal of Clinical Investigation, led by the same author, implanted small stainless-steel mesh chambers in rats and exposed them to GHK-Cu or to saline. The authors reported concentration-dependent increases in the dry mass, DNA, total protein, collagen and glycosaminoglycan content of the tissue that formed inside the chambers, with higher messenger RNA for type I and type III collagen. A control tripeptide, glutamyl-histidyl-proline, had no significant effect.

A 1999 follow-up in the Journal of Investigative Dermatology used the same chamber model to measure matrix metalloproteinases (MMPs), enzymes that break down and remodel connective tissue, and reported that GHK-Cu modulated the expression of MMP-2 and MMP-9. Both model connective-tissue build-up in a controlled space rather than a human wound, and say nothing about a cosmetic or a research vial.

Gene-expression analyses

A 2012 study in Genome Medicine by Campbell and colleagues profiled 64 samples from eight human lungs and identified 127 genes whose expression tracked the severity of emphysema, a form of chronic obstructive pulmonary disease (COPD). Searching the Broad Institute’s Connectivity Map, a reference database of how gene expression in cultured cells changes on exposure to compounds, they found that GHK produced the opposite pattern. In cultured lung fibroblasts from people with COPD, GHK was reported to organise the actin cytoskeleton, raise integrin beta-1 expression and restore contraction of collagen gels.

Pickart and Margolina’s 2018 review uses Connectivity Map data to report that GHK changed the expression of 31.2% of human genes by 50% or more. That shows the peptide is active in cell-based profiling, not what it would do in a person. Our tissue signalling guide explains why a cell response is not a clinical finding.

Copper tripeptide-1 vs research-grade GHK-Cu

GHK-Cu leads two separate lives. As copper tripeptide-1, it is an ingredient in finished skin-care formulations. As a research material, it is a lyophilised (freeze-dried) powder for laboratory work such as cell culture and analytical method development. Findings from one do not transfer to the other.

The published cosmetic evidence is limited. Pickart and Margolina’s 2018 review summarises 12-week studies of creams containing GHK-Cu applied to the face (71 women) or around the eyes (41 women), measuring skin density, thickness and wrinkles. Both are cited to 2002 conference abstracts rather than full peer-reviewed papers, and both tested finished formulations, not the peptide itself.

Getting the peptide into skin is a research question in its own right. A 2025 review in Molecules describes GHK-Cu as fairly hydrophilic, with limited permeation through the stratum corneum, the skin’s outer barrier, and found that liposome carriers for it have had little study and need better measurement methods. The 2020 Frontiers in Chemistry review describes modified forms, such as palmitoylated Pal-GHK, designed for stability and delivery.

GHK-Cu is also the largest component, by mass, of two research blends. Our guides to GLOW and KLOW explain them.

Thistle supplies GHK-Cu — 100mg Research Peptide at £44.99, with a batch laboratory report.

How to check the identity of a GHK-Cu batch

A copper complex needs more checks than a plain peptide, because both the peptide and the copper have to be confirmed. On a batch laboratory report for GHK-Cu, look for:

• Peptide identity by mass spectrometry (MS), showing the mass expected for GHK. A high-performance liquid chromatography (HPLC) retention time alone does not establish identity.
• Purity by HPLC, read as an area percentage. It describes how the sample separated, not how much copper is bound.
• Copper content, ideally by an elemental method such as inductively coupled plasma mass spectrometry (ICP-MS), so you can see whether peptide and copper are present in the expected ratio. A 2025 methods review describes element-specific approaches of this kind for GHK-Cu.
• Appearance, recorded as blue. A white powder sold as GHK-Cu needs explaining; a blue one still needs the tests above.
• The batch number, method and date, matching the vial label.

For study design, count the copper as a variable in its own right. The 1993 rat study included a control tripeptide. Designs that aim to separate the peptide from the metal can add arms with GHK alone and a copper salt alone, prepared and handled like the complex.

For the general method, see HPLC vs mass spectrometry and How to read a peptide COA (certificate of analysis). Thistle publishes the laboratory report for the current batch on each product page, and you can look up any batch on our batch report lookup. Keep the powder sealed, dry and protected from heat and light, and follow the vial label and our peptide storage guide.

Is GHK-Cu legal in the UK?

How GHK-Cu is regulated depends on how it is presented. In Great Britain, cosmetics fall under Regulation (EC) No 1223/2009 as it applies in GB, which defines a cosmetic product as a substance or mixture placed in contact with the external parts of the body, or the teeth and mouth, mainly to clean, perfume, change the appearance of, protect or keep them in good condition, or correct body odours. Skin-care products that list copper tripeptide-1 are generally regulated under that regime.

Claims decide where a product sits. Under the Human Medicines Regulations 2012, a product presented as treating or preventing disease in people, or used to restore, correct or modify physiological functions, is a medicinal product. The Medicines and Healthcare products Regulatory Agency (MHRA) says it judges presentation from all claims made for a product, explicit or implicit, including on websites and social media, and its guidance gives examples of skin products whose claims about conditions such as eczema would make them medicines or medical devices.

We have found no UK marketing authorisation for GHK-Cu as a medicine. Research-grade GHK-Cu is supplied for laboratory use, not presented as a cosmetic or a medicine. In April 2026 the MHRA said that if clinics make medicinal claims for peptide treatments, those products will be considered medicines. That is why this article makes no claims about skin or health.

This section is general information, not legal advice.

GHK-Cu FAQs

Is GHK-Cu the same as copper peptide?

Usually. In skin care, “copper peptide” almost always means GHK-Cu, listed on labels as copper tripeptide-1. Other peptide–copper complexes exist, so check the ingredient name or the batch report.

What is the difference between GHK and GHK-Cu?

GHK is the tripeptide glycyl-histidyl-lysine on its own. GHK-Cu is the same peptide with a copper(II) ion bound to it, which makes it blue. Check which form a paper actually tested before applying its findings.

Does GHK-Cu have side effects?

There are no human safety data for research-grade GHK-Cu, which is not for human use. Cosmetics containing copper tripeptide-1 are a separate, separately regulated category. We cannot advise on personal use.

How much does GHK-Cu cost in the UK?

Prices vary by supplier and pack size. At the time of writing, Thistle sells GHK-Cu 100mg at £44.99. Price says nothing about content or purity, so check the batch report.

Sources

• Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. Review.
• Pickart L, Margolina A. Copper peptides in skin and cell research: a review (2018). Cosmetics. 2018;5(2):29. Review.
• Pickart L, Freedman JH, Loker WJ, et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288:715–717. Cultured hepatoma cells.
• Bossak-Ahmad K, Wiśniewska MD, Bal W, et al. Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate. International Journal of Molecular Sciences. 2020;21(17):6190. Solution chemistry.
• Ufnalska I, Drew SC, Zhukov I, et al. Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction. Inorganic Chemistry. 2021;60(23):18048–18057. Laboratory chemistry.
• Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343–346. Human fibroblast cultures.
• Maquart FX, Bellon G, Chaqour B, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation. 1993;92(5):2368–2376. Rat wound-chamber model.
• Siméon A, Monier F, Emonard H, et al. Expression and Activation of Matrix Metalloproteinases in Wounds: Modulation by the Tripeptide–Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+. Journal of Investigative Dermatology. 1999;112(6):957–964. Rat wound-chamber model.
• Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Medicine. 2012;4:67. Human lung tissue, Connectivity Map and cultured fibroblasts.
• Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Frontiers in Chemistry. 2020;8:572923. Review.
• Ogórek K, Nowak K, Wadych E, et al. Measuring skin permeation of liposome-encapsulated GHK-Cu: a methods review (2025). Molecules. 2025;30(1):136. Review.
• legislation.gov.uk. Regulation (EC) No 1223/2009 on cosmetic products, Article 2: definitions. Version as it applies in Great Britain.
• Medicines and Healthcare products Regulatory Agency. MHRA Guidance Note 8: A guide to what is a medicinal product. September 2025.
• legislation.gov.uk. The Human Medicines Regulations 2012, regulation 2: medicinal products.
• Aesthetics Journal. MHRA investigates clinics following peptide claims. 15 April 2026.

Published by Thistle BioLabs, a UK supplier of research materials. This article summarises external research, not studies conducted by Thistle. Educational information only; no medical advice or recommendation for personal use.